Gynecologic Oncology

September 13, 2022

New Clinician Spotlight: Catherine Watson

Catherine Watson, MD, has joined Vanderbilt University Medical Center as an assistant professor in the Department of Obstetrics and Gynecology, specializing in gynecologic oncology.

By VUMC News and Communications

March 12, 2019

VUMC Mourns the Passing of Howard W. Jones III, MD

Howard W. Jones III, MD, professor of Obstetrics and Gynecology, former chair of the department and a world-renowned researcher into the causes and treatment of gynecologic cancer, died unexpectedly in his sleep on Saturday, March 9. He was 76.

By Wayne Wood

August 11, 2015

Drug combos enhance ovarian cancer cell death

Drugs that target DNA damage improve ovarian cancer cell response to platinum chemotherapies, suggesting new therapeutic opportunities.

By Leigh MacMillan

August 22, 2013

Overcoming resistance in ovarian cancer

The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments.

By Leigh MacMillan

December 24, 2012

A drug combo for ovarian cancer

Combining another drug with platinum-based chemotherapies may be more effective against ovarian cancer.

By Leigh MacMillan